Browsing by Author Thongsawat S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 18 of 18
Issue DateTitleAuthor(s)
2003Bioequivalence Studies of Itraconazole CapsulesKaewvichit S.; Taesotikul W.; Duangrat C.; Thongsawat S.; Niwatananun N.; Niwatananun K.; Wongsinsup C.
2003Bioequivalence Studies of Itraconazole CapsulesKaewvichit S.; Taesotikul W.; Duangrat C.; Thongsawat S.; Niwatananun N.; Niwatananun K.; Wongsinsup C.
2008Bioequivalence study of the two 1.5 g cefoperazone and sulbactam IM injections in Thai healthy male volunteersKaewvichit S.; Yotsawimonwat S.; Taesotikul W.; Niwatananun W.; Duangrat C.; Wongsinsup C.; Thongsawat S.; Salee P.
2008Bioequivalence study of the two 1.5 g cefoperazone and sulbactam IM injections in Thai healthy male volunteersKaewvichit S.; Yotsawimonwat S.; Taesotikul W.; Niwatananun W.; Duangrat C.; Wongsinsup C.; Thongsawat S.; Salee P.
2004Clinicopathologic Study of Hepatic Penicillium marneffei in Northern ThailandYousukh A.; Jutavijittum P.; Pisetpongsa P.; Chitapanarux T.; Thongsawat S.; Senba M.; Toriyama K.
2011Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapyKumthip K.; Pantip C.; Chusri P.; Thongsawat S.; O'Brien A.; Nelson K.E.; Maneekarn N.
2013Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis BWang Y.; Thongsawat S.; Gane E.J.; Liaw Y.-F.; Jia J.; Hou J.; Chan H.L.Y.; Papatheodoridis G.; Wan M.; Niu J.; Bao W.; Trylesinski A.; Naoumov N.V.
2007Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern ThailandNantachit N.; Thaikruea L.; Thongsawat S.; Leetrakool N.; Fongsatikul L.; Sompan P.; Fong YL.; Nichols D.; Ziermann R.; Ness P.; Nelson KE.
2005Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from ThailandKuang S.-Y.; Lekawanvijit S.; Maneekarn N.; Thongsawat S.; Brodovicz K.; Nelson K.; Groopman J.D.
2004Hepatitis C Virus (HCV) Core Antigen Assay to Detect Ongoing HCV Infection in Thai Injection Drug UsersNetski D.M.; Wang X.-H.; Mehta S.H.; Nelson K.; Celentano D.; Thongsawat S.; Maneekarn N.; Suriyanon V.; Jittiwutikorn J.; Thomas D.L.; Ticehurst J.R.
2014Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapyKumthip K.; Chusri P.; Pantip C.; Thongsawat S.; O'Brien A.; Nelson K.E.; Maneekarn N.
2012Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signalingKumthip K.; Chusri P.; Jilg N.; Zhao L.; Fusco D.N.; Zhao H.; Goto K.; Cheng D.; Schaefer E.A.; Zhang L.; Pantip C.; Thongsawat S.; O'Brien A.; Peng L.F.; Maneekarn N.; Chung R.T.; Lin W.
2014Normal solid gastric emptying values measured by scintigraphy using asian-style meal: A multicenter study in healthy volunteersVasavid P.; Chaiwatanarat T.; Pusuwan P.; Sritara C.; Roysri K.; Namwongprom S.; Kuanrakcharoen P.; Premprabha T.; Chunlertrith K.; Thongsawat S.; Sirinthornpunya S.; Ovartlarnporn B.; Kachintorn U.; Leelakusolvong S.; Kositchaiwat C.; Chakkaphak S.; Gonlachanvit S.
2005Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis BLau G.K.K.; Piratvisuth T.; Kang X.L.; Marcellin P.; Thongsawat S.; Cooksley G.; Gane E.; Fried M.W.; Wan C.C.; Seung W.P.; Wen Y.C.; Berg T.; Flisiak R.; McCloud P.; Pluck N.
2007Per rectal portal scintigraphy as a useful tool for predicting esophageal variceal bleeding in cirrhotic patientsChitapanarux T.; Praisontarangkul O.-A.; Thongsawat S.; Pisespongsa P.; Leerapun A.
2012Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3Pianko S.; Zeuzem S.; Chuang W.-L.; Foster G.R.; Sarin S.K.; Flisiak R.; Lee C.-M.; Andreone P.; Piratvisuth T.; Shah S.; Sood A.; George J.; Gould M.; Komolmit P.; Thongsawat S.; Tanwandee T.; Rasenack J.; Li Y.; Pang M.; Yin Y.; Feutren G.; Jacobson I.M.
2012Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3Pianko S.; Zeuzem S.; Chuang WL.; Foster GR.; Sarin SK.; Flisiak R.; Lee CM.; Andreone P.; Piratvisuth T.; Shah S.; Sood A.; George J.; Gould M.; Komolmit P.; Thongsawat S.; Tanwandee T.; Rasenack J.; Li Y.; Pang M.; Yin Y.; Feutren G.; Jacobson IM.; for the B2202 Study Team.
2004Risk factors for hepatitis C virus infection among blood donors in northern ThailandThaikruea L.; Thongsawat S.; Maneekarn N.; Netski D.; Thomas DL.; Nelson KE.